Pacific Biosciences of California, Inc. (PACB)
1.285
-0.06
(-4.81%)
USD |
NASDAQ |
Aug 24, 16:00
1.33
+0.04
(+3.50%)
After-Hours: 20:00
Pacific Biosciences of California Shareholders Equity (Quarterly) : -33.21M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -33.21M |
| March 31, 2026 | 2.366M |
| December 31, 2025 | 5.349M |
| September 30, 2025 | 36.09M |
| June 30, 2025 | 61.49M |
| March 31, 2025 | 91.64M |
| December 31, 2024 | 506.59M |
| September 30, 2024 | 453.12M |
| June 30, 2024 | 492.70M |
| March 31, 2024 | 649.02M |
| December 31, 2023 | 701.30M |
| September 30, 2023 | 763.74M |
| June 30, 2023 | 642.00M |
| March 31, 2023 | 692.12M |
| December 31, 2022 | 562.90M |
| September 30, 2022 | 626.59M |
| June 30, 2022 | 681.89M |
| March 31, 2022 | 734.58M |
| December 31, 2021 | 790.99M |
| September 30, 2021 | 840.81M |
| June 30, 2021 | 258.24M |
| March 31, 2021 | 280.55M |
| December 31, 2020 | 335.49M |
| September 30, 2020 | 129.50M |
| June 30, 2020 | 41.39M |
| Date | Value |
|---|---|
| March 31, 2020 | 60.40M |
| December 31, 2019 | 54.92M |
| September 30, 2019 | 51.01M |
| June 30, 2019 | 75.75M |
| March 31, 2019 | 94.85M |
| December 31, 2018 | 114.06M |
| September 30, 2018 | 131.88M |
| June 30, 2018 | 85.47M |
| March 31, 2018 | 102.74M |
| December 31, 2017 | 86.10M |
| September 30, 2017 | 101.41M |
| June 30, 2017 | 115.86M |
| March 31, 2017 | 69.18M |
| December 31, 2016 | 84.67M |
| September 30, 2016 | 98.68M |
| June 30, 2016 | 108.07M |
| March 31, 2016 | 88.78M |
| December 31, 2015 | 73.54M |
| September 30, 2015 | 41.37M |
| June 30, 2015 | 33.84M |
| March 31, 2015 | 40.47M |
| December 31, 2014 | 54.95M |
| September 30, 2014 | 53.04M |
| June 30, 2014 | 59.02M |
| March 31, 2014 | 75.52M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Illumina, Inc. | 2.838B |
| Agilent Technologies, Inc. | 7.122B |
| Bio-Rad Laboratories, Inc. | 7.174B |
| Danaher Corp. | 52.58B |
| Thermo Fisher Scientific, Inc. | 52.68B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 751.85M |
| Total Liabilities (Quarterly) | 785.06M |
| Debt to Equity Ratio | -21.26 |
| Current Ratio | 4.922 |
| Net Debt Paydown Yield | -0.27% |